Overview The Effects of Neprilysin on Glucagon-like Peptide-1 Status: Completed Trial end date: 2019-05-14 Target enrollment: Participant gender: Summary In the current study we wish to investigate the effects on glucagon-like peptide-1 (GLP-1) of a neprilysin inhibitor Phase: Phase 4 Details Lead Sponsor: Nicolai Jacob Wewer AlbrechtsenTreatments: Dipeptidyl-Peptidase IV InhibitorsGlucagonGlucagon-Like Peptide 1LCZ 696Sacubitril and valsartan sodium hydrate drug combinationSitagliptin Phosphate